Literature DB >> 36262806

Association of Lipopolysaccharide-Toll-Like Receptor 4 Signaling and Microalbuminuria in Patients with Type 2 Diabetes Mellitus.

Lijuan Zhang1, Yuanjun Zhang2,3, Juxiang Liu2,3, Yonghong Li4, Jinxing Quan2,3.   

Abstract

Purpose: Intestinal flora imbalance has been implicated in the activation of innate immunity in the kidneys. However, little is known about the potential links between lipopolysaccharide (LPS)-toll-like. receptor 4 (TLR4) signaling activated by intestinal barrier dysfunction and microalbuminuria in type 2 diabetes mellitus (T2DM). Patients and
Methods: 61 patients with T2DM were stratified based on the absence (n=32) or presence (n=29) of microalbuminuria. There were also 28 control subjects. Urinary albumin excretion rate (UAER), serum levels of LPS, D-lactic acid (DLA), diamine oxidase (DAO), fasting blood glucose (FBG), interleukin-6 (IL-6), glycosylated hemoglobin A1 (HbA1c), and high-sensitivity C-reactive protein (hs-CRP), and TLR4 expression in peripheral blood mononuclear cells (PBMCs) were measured.
Results: hs-CRP, IL-6, LPS, DLA, DAO, and TLR4 were markedly increased in subjects with T2DM compared to the controls (P < 0.05 for all). Moreover, LPS was positively correlated with FBG, HbA1c, hs-CRP, IL-6, UAER, DLA, DAO, and TLR4 (P < 0.05 for all). In addition, TLR4 was positively correlated with UAER, hs-CRP, FBG, DLA, HbA1c, and LPS (P < 0.05 for all). In regression analyses, TLR4, LPS, HbA1c, and hs-CRP were independently associated with UAER (P < 0.05 for all), while FBG, LPS, TLR4, and hs-CRP (P < 0.05 for all) were found to be risk factors for microalbuminuria in T2DM.
Conclusion: Intestinal integrity is compromised in subjects with T2DM, and the activation of LPS-TLR4 signaling might play an important role in the development of microalbuminuria in T2DM.
© 2022 Zhang et al.

Entities:  

Keywords:  intestinal mucosal barrier; lipopolysaccharide; microalbuminuria; toll-like receptor 4; type 2 diabetes mellitus

Year:  2022        PMID: 36262806      PMCID: PMC9575588          DOI: 10.2147/DMSO.S377776

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.249


  45 in total

1.  Use of the microbiome in the management of children with type 2 diabetes mellitus.

Authors:  Preneet Cheema Brar; Brenda Kohn
Journal:  Curr Opin Pediatr       Date:  2019-08       Impact factor: 2.856

Review 2.  Gut microbiota, obesity and diabetes.

Authors:  Elaine Patterson; Paul M Ryan; John F Cryan; Timothy G Dinan; R Paul Ross; Gerald F Fitzgerald; Catherine Stanton
Journal:  Postgrad Med J       Date:  2016-02-24       Impact factor: 2.401

Review 3.  The gut-kidney axis.

Authors:  Pieter Evenepoel; Ruben Poesen; Björn Meijers
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

4.  Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.

Authors:  Ishwarlal Jialal; Angela M Major; Sridevi Devaraj
Journal:  J Diabetes Complications       Date:  2014-07-12       Impact factor: 2.852

5.  Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.

Authors:  Daniela Verzola; Laura Cappuccino; Elena D'Amato; Barbara Villaggio; Fabio Gianiorio; Mariano Mij; Alchiede Simonato; Francesca Viazzi; Gennaro Salvidio; Giacomo Garibotto
Journal:  Kidney Int       Date:  2014-04-30       Impact factor: 10.612

Review 6.  Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier García-Pérez
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

Review 7.  LPS, TLR4 and infectious disease diversity.

Authors:  Samuel I Miller; Robert K Ernst; Martin W Bader
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

Review 8.  Cardiovascular Disease and Diabetic Kidney Disease.

Authors:  Muhammad Maqbool; Mark E Cooper; Karin A M Jandeleit-Dahm
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299

9.  Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes.

Authors:  Somlak Chuengsamarn; Suthee Rattanamongkolgul; Gunya Sittithumcharee; Siwanon Jirawatnotai
Journal:  Diabetes Metab Syndr       Date:  2016-08-22

10.  Recombinant TsP53 modulates intestinal epithelial barrier integrity via upregulation of ZO‑1 in LPS‑induced septic mice.

Authors:  Jia Xu; Zhihao Liu; Wei Zhan; Ren Jiang; Chunhua Yang; Hong Zhan; Yan Xiong
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.